AstraZeneca Plc is to make an undisclosed up-front cash payment to PTC Therapeutics Inc for access to technology that regulates the rate and timing of protein production in the cell. The goal is to discover new small molecule drugs for cancer. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals Research & University News
